Efficacy and Safety of the third dose of mRNA COVID-19 Vaccine in healthy volunteers: An observational study.
Not Applicable
- Conditions
- Healthy volunteers
- Registration Number
- JPRN-UMIN000046211
- Lead Sponsor
- Kobe City Medical Center General Hospital, Department of Hematology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Those that the principal investigator or sub-investigator deems inappropriate for participation in the study 2) Patients with a history or coexistence of immunosuppressive medication, autoimmune diseases (systemic lupus erythematosus, Sjogren's syndrome, dermatomyositis/polymyositis, mixed connective tissue disease, systemic scleroderma, rheumatoid arthritis, polymyalgia rheumatica, psoriatic arthritis, spondyloarthritis and related diseases, vasculitis syndrome, inflammatory bowel disease, Guillain-Barre syndrome, multiple sclerosis, neuromyelitis optica) Multiple sclerosis, neuromyelitis optica). 3) Patients with a history of COVID-19 4) Patients who are unable to communicate with others
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method